Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-26 Sale | 2024-03-27 4:30 pm | NewAmsterdam Pharma Co N.V. | NAMS | Kastelein Johannes Jacob Pieter Chief Scientific Officer | 190,476 | $21.5 | $4,095,234 | 970,229 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-26 Exercise | 2024-03-27 4:30 pm | N/A 2031-07-06 | NewAmsterdam Pharma Co N.V. | NAMS | Kastelein Johannes Jacob Pieter Chief Scientific Officer | 201,673 | $0 | 970,229 (Indirect) | View |
| 2024-03-26 Tax Withholding | 2024-03-27 4:30 pm | N/A N/A | NewAmsterdam Pharma Co N.V. | NAMS | Kastelein Johannes Jacob Pieter Chief Scientific Officer | 11,197 | $22.72 | 970,229 (Indirect) | View |
| 2024-01-01 Option Award | 2024-01-03 5:17 pm | N/A 2034-01-01 | NewAmsterdam Pharma Co N.V. | NAMS | Kastelein Johannes Jacob Pieter Chief Scientific Officer | 500,000 | $0 | 500,000 (Direct) | View |
Ownership | 2023-12-29 4:30 pm | N/A 2033-01-01 | NewAmsterdam Pharma Co N.V. | NAMS | Kastelein Johannes Jacob Pieter Chief Scientific Officer | 0 | $0 | 2,620,975 (Direct) | View |